Trial reportArchives of gynecology and obstetrics1996
Randomised trial of outpatient induction of labor with vaginal PGE2 at 40-41 weeks of gestation versus expectant management.
Trial report in Archives of gynecology and obstetrics, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 6 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Induction of labour at or beyond 37 weeks' gestation.The Cochrane database of systematic reviews · 2020Pooled it
- Induction of labour for improving birth outcomes for women at or beyond term.The Cochrane database of systematic reviews · 2018Pooled it
- Pharmacological and mechanical interventions for labour induction in outpatient settings.The Cochrane database of systematic reviews · 2017Pooled it
- Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.The Cochrane database of systematic reviews · 2014Pooled it
- Induction of labour for improving birth outcomes for women at or beyond term.The Cochrane database of systematic reviews · 2012Pooled it
- Different methods for the induction of labour in outpatient settings.The Cochrane database of systematic reviews · 2010Pooled it
- The impact of the active management of risk in pregnancy at term on birth outcomes: a randomized clinical trial.American journal of obstetrics and gynecology · 2008Trial
- A Tribute to Nancy C. Chescheir, MD.Obstetrics and gynecology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two hundred consecutive women with uncomplicated pregnancies, at or within 4 days of their expected date of confinement, were prospectively randomized into 2 groups. One group had expectant management, with twice weekly surveillance tests, while the other group had 3 mg of vaginal prostaglandin E2 as outpatient treatment. There were 104 women in the expectant group and 70 in the induction group (26 women allocated to induction preferred no treatment). The average number of days to delivery was 1.6 in the induction group and 5.2 in the expectant group (p < 0.001). While meconium was much less frequent in the induction group (p < 0.002), all other outcome measures, including cesarean section rates, incidence of macrosomia, and Apgar scores, were similar in the two groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.